The 2001 Veylien Henderson Award of the Society of Toxicology of Canada. Positive and negative transcriptional regulation of cytochromes P450 by polycyclic aromatic hydrocarbons

Canadian Journal of Physiology and Pharmacology

Volumn 81, Issue 1, 2003, Pages 59-77

  Riddick, David S ^a   Lee, Chunja ^a   Bhathena, Anahita ^a   Timsit, Yoav E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Aromatic hydrocarbon receptor; Aromatic hydrocarbons; Cytochrome P450; Growth hormone; Transcriptional regulation

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 3 METHYLCHOLANTHRENE; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450; CYTOCHROME P450 2C11; GROWTH HORMONE; POLYCYCLIC AROMATIC HYDROCARBON;

CELL CULTURE; DNA FLANKING REGION; DRUG METABOLISM; ENZYME REGULATION; GENE EXPRESSION REGULATION; GROWTH HORMONE RELEASE; HUMAN; HYPOPHYSECTOMY; LIVER CELL; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; REPORTER GENE; REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; AWARDS AND PRIZES; CYTOCHROME P-450 CYP1A1; ENVIRONMENTAL POLLUTANTS; GENE EXPRESSION REGULATION; HUMANS; HYDROCARBONS, AROMATIC; LIVER; MALE; MODELS, BIOLOGICAL; PITUITARY GLAND; RATS; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION; STEROID 16-ALPHA-HYDROXYLASE; TRANSCRIPTION, GENETIC;

EID: 0037247766     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y03-003     Document Type: Review

References (196)

1. Adachi, J., Mori, Y., Matsui, S., Takigami, H., Fujino, J., Kitagawa, H., Miller, C.A., Kato, T., Saeki, K., and Matsuda, T. 2001. Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J. Biol. Chem. 276: 31 475-31 478.
2. Afsar, A., Lee, C., and Riddick, D.S. 1996. Modulation of the expression of constitutive rat hepatic cytochrome P450 isozymes by 5-fluorouracil. Can. J. Physiol. Pharmacol. 74: 150-156.
3. Agrawal, A.K., and Shapiro, B.H. 2000. Differential expression of gender-dependent hepatic isoforms of cytochrome P-450 by pulse signals in the circulating masculine episodic growth hormone profile of the rat. J. Pharmacol. Exp. Ther. 292: 228-237.
4. Al-Turk, W.A., Stohs, S.J., and Roche, E.B. 1981. Effect of hypophysectomy and castration on hepatic, pulmonary and intestinal aryl hydrocarbon hydroxylase activities in the rat. J. Pharmacol. Exp. Ther. 216: 492-495.
5. Anderson, M.D., Bandiera, S.M., Chang, T.K.H., and Bellward, G.D. 1998. Effect of androgen administration during puberty on hepatic CYP2C11, CYP3A, and CYP2A1 expression, in adult female rats. Drug Metab. Dispos. 26: 1031-1038.
6. Bandiera, S., and Dworschak, C. 1992. Effects of testosterone and estrogen on hepatic levels of cytochrome-P450-2C7 and cytochrome-P450-2C11 in the rat. Arch. Biochem. Biophys. 296: 286-295.
7. Bartosiewicz, M.J., Jenkins, D., Penn, S., Emery, J., and Buckpitt, A. 2001. Unique gene expression patterns in liver and kidney associated with exposure to chemical toxicants. J. Pharmacol. Exp. Ther. 297: 895-905.
8. Beischlag, T.V., Wang, S., Rose, D.W., Torchia, J., Reisz-Porszasz, S., Muhammad, K., Nelson, W.E., Probst, M.R., Rosenfeld, M.G., and Hankinson, O. 2002. Recruitment of the NCoA/SRC-1/p160 family of transcriptional coactivators by the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator complex. Mol. Cell. Biol. 22: 4319-4333.
9. Bergeron, R.M., Serron, S.C., Rinehart, J.J., Cawley, G.F., and Backes, W.L. 1998. Pituitary component of the aromatic hydrocarbon-mediated expression of CYP2B and CYP2C11. Xenobiotica, 28: 303-312.
10. Bertazzi, P.A., Consonni, D., Bachetti, S., Rubagotti, M., Baccarelli, A., Zocchetti, C., and Pesatori, A.C. 2001. Health effects of dioxin exposure: a 20-year mortality study. Am. J. Epidemiol. 153: 1031-1044.
11. Bhathena, A., Lee, C., and Riddick, D.S. 2002. Suppression of cytochrome P450 2C11 by aromatic hydrocarbons: mechanistic insights from studies of the 5′flanking region of the CYP2C11 gene. Drug Metab. Dispos. 30: 1385-1392.
12. Bjeldanes, L.F., Kim, J.Y., Grose, K.R., Bartholomew, J.C., and Bradfield, C.A. 1991. Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc. Natl. Acad. Sci. U.S.A. 88: 9543-9547.
13. Bradfield, C.A., Glover, E., and Poland, A. 1991. Purification and N-terminal amino acid sequence of the Ah receptor from the C57BL/6J mouse. Mol. Pharmacol. 39: 13-19.
14. Bradlow, H.L., Michnovicz, J.J., Telang, N.T., and Osborne, M.P. 1991. Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis, 12: 1571-1574.
15. Burbach, K.M., Poland, A., and Bradfield, C.A. 1992. Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc. Natl. Acad. Sci. U.S.A. 89: 8185-8189.
16. Burke, M.D., Orrenius, S., and Gustafsson, J.-A. 1978. Pituitary involvement in the sexual differentiation and 3-methylcholanthrene induction of rat liver microsomal monooxygenases. Biochem. Pharmacol. 27: 1125-1128.
17. Butler, M.A., Guengerich, F.P., and Kadlubar, F.K. 1989. Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4′-methylenebis(2-chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome P-450 monooxygenases. Cancer Res. 49: 25-31.
18. Butler, R.A., Kelley, M.L., Powell, W.H., Hahn, M.E., and VanBeneden, R.J. 2001. An aryl hydrocarbon receptor (AHR) homologue from the soft-shell clam, Mya arenaria: evidence that invertebrate AHR homologues lack 2,3,7,8-tetrachlorodibenzo-p-dioxin and β-naphthoflavone binding. Gene, 278: 223-234.
19. Cadario, B.J., Bellward, G.D., Bandiera, S., Chang, T.K.H., Ko, W.W.W., Lemieux, E., and Pak, R.C.K. 1992. Imprinting of hepatic microsomal cytochrome-P-450 enzyme activities and cytochrome-P-450IIC11 by peripubertal administration of testosterone in female rats. Mol. Pharmacol. 41: 981-988.
20. Carlstedt-Duke, J.M., Elfstrom, G., Hogberg, B., and Gustaffson, J.-A. 1979. Ontogeny of the rat hepatic receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin and its endocrine independence. Cancer Res. 39: 4653-4656.
21. Carver, L.A., and Bradfield, C.A. 1997. Ligand-dependent interaction of the aryl hydrocarbon receptor with a novel immunophilin homolog in vivo. J. Biol. Chem. 272: 11 452-11 456.
22. Casper, R.F., Quesne, M., Rogers, I.M., Shirota, T., Jolivet, A., Milgrom, E., and Savouret, J.F. 1999. Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. Mol. Pharmacol. 56: 784-790.
23. Chang, T.K.H., and Bellward, G.D. 1996. Peripubertal androgen imprinting of rat hepatic cytochrome P450 2C11 and steroid 5α-reductase: pretranslational regulation and impact on microsomal drug activation. J. Pharmacol. Exp. Ther. 278: 1383-1391.
24. Chen, J.-Q., Nikolova-Karakashian, M., Merrill, A.H., and Morgan, E.T. 1995a. Regulation of cytochrome P4502C11 (CYP2C11) gene expression by interleukin-1, sphingomyelin hydrolysis, and ceramides in rat hepatocytes. J. Biol. Chem. 270: 25 233-25 238.
25. Chen, J.-Q., Strom, A., Gustafsson, J.-A., and Morgan, E.T. 1995b. Suppression of the constitutive expression of cytochrome P-450 2C11 by cytokines and interferons in primary cultures of rat hepatocytes: comparison with induction of acute-phase genes and demonstration that CYP2C11 promoter sequences are involved in the suppressive response to interleukins 1 and 6. Mol. Pharmacol. 47: 940-947.
26. Choi, H.K., and Waxman, D.J. 2000. Plasma growth hormone pulse activation of hepatic JAK-STAT5 signaling: developmental regulation and role in male-specific liver gene expression. Endocrinology, 141: 3245-3255.
27. Ciolino, H.P., and Yeh, G.C. 1999. Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol. Pharmacol. 56: 760-767.
28. Clark, A.R., and Docherty, K. 1993. Negative regulation of transcription in eukaryotes. Biochem. J. 296: 521-541.
29. Corton, J.C., Fan, L.Q., Brown, S., Anderson, S.P., Bocos, C., Cattley, R.C., Mode, A., and Gustafsson, J.-A. 1998. Down-regulation of cytochrome P450 2C family members and positive acute-phase response gene expression by peroxisome proliferator chemicals. Mol. Pharmacol. 54: 463-473.
30. Dannan, G.A., Guengerich, F.P., Kaminsky, L.S., and Aust, S.D. 1983. Regulation of cytochrome P-450: immunochemical quantitation of eight isozymes in liver microsomes of rats treated with polybrominated biphenyl congeners. J. Biol. Chem. 258: 1282-1288.
31. Davey, H.W., Park, S.H., Grattan, D.R., McLachlan, M.J., and Waxman, D.J. 1999. STAT5b-deficient mice are growth hormone pulse-resistant: role of STAT5b in sex-specific liver P450 expression. J. Biol. Chem. 274: 35 331-35 336.
32. Denis, M., Cuthill, S., Wikstrom, A.-C., Poellinger, L., and Gustafsson, J.-A. 1988. Association of the dioxin receptor with the Mr 90,000 heat shock protein: a structural kinship with the glucocorticoid receptor. Biochem. Biophys. Res. Commun. 155: 801-807.
33. Denison, M.S., Harper, P.A., and Okey, A.B. 1986. Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin: codistribution of unoccupied receptor with cytosolic marker enzymes during fractionation of mouse liver, rat liver and cultured Hepa-1c1 cells. Eur. J. Biochem. 155: 223-229.
34. Denison, M.S., Fisher, J.M., and Whitlock, J.P. 1988. Inducible, receptor-dependent protein-DNA interactions at a dioxin-responsive transcriptional enhancer. Proc. Natl. Acad. Sci. U.S.A. 85: 2528-2532.
35. Dolwick, K.M., Schmidt, J.V., Carver, L.A., Swanson, H.I., and Bradfield, C.A. 1993. Cloning and expression of a human Ah receptor cDNA. Mol. Pharmacol. 44: 911-917.
36. Duan, R.Q., Porter, W., Samudio, I., Vyhlidal, C., Kladde, M., and Safe, S. 1999. Transcriptional activation of c-fos protooncogene by 17β-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition. Mol. Endocrinol. 13: 1511-1521.
37. Duncan, D.M., Burgess, E.A., and Duncan, I. 1998. Control of distal antennal identity and tarsal development in Drosophila by spineless-aristapedia, a homolog of the mammalian dioxin receptor. Genes Dev. 12: 1290-1303.
38. Ema, M., Sogawa, K., Watanabe, N., Chujoh, Y., Matsushita, N., Gotoh, O., Funae, Y., and Fujii-Kuriyama, Y. 1992. cDNA cloning and structure of mouse putative Ah receptor. Biochem. Biophys. Res. Commun. 184: 246-253.
39. Emi, Y., and Omura, T. 1988. Synthesis of sex-specific forms of cytochrome P-450 in rat liver is transiently suppressed by hepatic monooxygenase inducers. J. Biochem. 104: 40-43.
40. Fernandez-Salguero, P., Pineau, T., Hilbert, D.M., McPhail, T., Lee, S.S.T., Kimura, S., Nebert, D.W., Rudikoff, S., Ward, J.M., and Gonzalez, F.J. 1995. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science (Washington, D.C.), 268: 722-726.
41. Fernandez-Salguero, P.M., Hilbert, D.M., Rudikoff, S., Ward, J.M., and Gonzalez, F.J. 1996. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol. Appl. Pharmacol. 140: 173-179.
42. Frueh, F.W., Hayashibara, K.C., Brown, P.O., and Whitlock, J.P. 2001. Use of cDNA microarrays to analyze dioxin-induced changes in human liver gene expression. Toxicol. Lett. 122: 189-203.
43. 2 expression in a human keratinocyte cell line involves both transcriptional and post-transcriptional control. J. Biol. Chem. 267: 24 591-24 595.
44. Garrison, P.M., Tullis, K., Aarts, J.M.M.J.G., Brouwer, A., Giesy, J.P., and Denison, M.S. 1996. Species-specific recombinant cell lines as bioassay systems for the detection of 2,3,7,8-tetrachlorodibenzo-p-dioxin-like chemicals. Fund. Appl. Toxicol. 30: 194-203.
45. Gerhold, D., Lu, M.Q., Xu, J., Austin, C., Caskey, C.T., and Rushmore, T. 2001. Monitoring expression of genes involved in drug metabolism and toxicology using DNA microarrays. Physiol. Genomics, 5: 161-170.
46. Giannone, J.V., Li, W., Probst, M., and Okey, A.B. 1998. Pro-longed depletion of AH receptor without alteration of receptor mRNA levels after treatment of cells in culture with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem. Pharmacol. 55: 489-497.
47. Gillesby, B.E., Stanostefano, M., Porter, W., Safe, S., Wu, Z.F., and Zacharewski, T.R. 1997. Identification of a motif within the 5′ regulatory region of pS2 which is responsible for AP-1 binding and TCDD-mediated suppression. Biochemistry, 36: 6080-6089.
48. 3-450 mRNA levels by 3-methylcholanthrene. Mol. Pharmacol. 26: 117-121.
49. Goodwin, B., Hodgson, E., and Liddle, C. 1999. The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Mol. Pharmacol. 56: 1329-1339.
50. Gu, Y.Z., Hogenesch, J.B., and Bradfield, C.A. 2000. The PAS superfamily: sensors of environmental and developmental signals. Annu. Rev. Pharmacol. Toxicol. 40: 519-561.
51. Guengerich, F.P., Dannan, G.A., Wright, S.T., Martin, M.V., and Kaminsky, K.S. 1982. Purification and characterization of liver microsomal cytochromes P-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or β-naphthoflavone. Biochemistry, 21: 6019-6030.
52. Gustafsson, J.-A., and Ingelman-Sundberg, M. 1979. Changes in steroid hormone metabolism in rat liver microsomes following administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Biochem. Pharmacol. 28: 497-499.
53. Hahn, M.E. 1998. The aryl hydrocarbon receptor: a comparative perspective. Comp. Biochem. Physiol. 121: 23-53.
54. Harper, P.A., Golas, C.L., and Okey, A.B. 1988. Characterization of the Ah receptor and aryl hydrocarbon hydroxylase induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin and benz(a)anthracene in the human A431 squamous cell carcinoma line. Cancer Res. 48: 2388-2395.
55. Harper, P.A., Wong, J.M.Y., Lam, M.S.M., and Okey, A.B. 2002. Polymorphisms in the human AH receptor. Chem. Biol. Interact. 141: 161-187.
56. Heath-Pagliuso, S., Rogers, W.J., Tullis, K., Seidel, S.D., Cenijn, P.H., Brouwer, A., and Denison, M.S. 1998. Activation of the Ah receptor by tryptophan and tryptophan metabolites. Biochemistry, 37: 11 508-11 515.
57. Henderson, C.J., and Wolf, C.R. 1992. Molecular analysis of cytochrome P450s in the CYP2 gene family. Prog. Drug Metab. 13: 73-139.
58. Hestermann, E.V., Stegeman, J.J., and Hahn, M.E. 2000. Relative contributions of affinity and intrinsic efficacy to aryl hydrocarbon receptor ligand potency. Toxicol. Appl. Pharmacol. 168: 160-172.
59. Hestermann, E.V., Stegeman, J.J., and Hahn, M.E. 2002. Serum withdrawal leads to reduced aryl hydrocarbon receptor expression and loss of cytochrome P4501A inducibility in PLHC-1 cells. Biochem. Pharmacol. 63: 1405-1414.
60. Hines, R.N., Luo, Z., Cresteil, T., Ding, X., Prough, R.A., Fitzpatrick, J.L., Ripp, S.L., Falkner, K.C., Ge, N.L., Levine, A., and Elferink, C.J. 2001. Molecular regulation of genes encoding xenobiotic-metabolizing enzymes: mechanisms involving endogenous factors. Drug Metab. Dispos. 29: 623-633.
61. Hoffman, E.C., Reyes, H., Chu, F.F., Sander, F., Conley, L.H., Brooks, B.A., and Hankinson, O. 1991. Cloning of a factor required for activity of the Ah (dioxin) receptor. Science (Washington, D.C.) 252: 954-958.
62. Hogenesch, J.B., Chan, W.K., Jackiw, V.H., Brown, R.C., Gu, Y.Z., Pray-Grant, M., Perdew, G.H., and Bradfield, C.A. 1997. Characterization of a subset of the basic-helix-loop-helix-PAS superfamily that interacts with components of the dioxin signaling pathway. J. Biol. Chem. 272: 8581-8593.
63. Hook, G.E.R., Haseman, J.K., and Lucier, G.W. 1975. Induction and suppression of hepatic and extrahepatic microsomal foreign-compound-metabolizing enzyme systems by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Chem. Biol. Interact. 10: 199-214.
64. Iber, H., Chen, Q., Sewer, M., and Morgan, E.T. 1997. Regulation of hepatic cytochrome P4502C11 by glucocorticoids. Arch. Biochem. Biophys. 345: 305-310.
65. Iber, H., Chen, Q., Cheng, P.Y., and Morgan, E.T. 2000. Suppression of CYP2C11 gene transcription by interleukin-1 mediated by NF-κB binding at the transcription start site. Arch. Biochem. Biophys. 377: 187-194.
66. 1-450 in wild type and variant mouse hepatoma cells. J. Biol. Chem. 258: 10 390-10 394.
67. 1-450 gene transcription by 2,3,7,8-tetrachlorodibenzo-p-dioxin in wild type and variant mouse hepatoma cells. J. Biol. Chem. 259: 5400-5402.
68. Jellinck, P.H., Forkert, P.G., Riddick, D.S., Okey, A.B., Michnovicz, J.J., and Bradlow, H.L. 1993. Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation. Biochem. Pharmacol. 45: 1129-1136.
69. Ji, S.N., Guan, R., Frank, S.J., and Messina, J.L. 1999. Insulin inhibits growth hormone signaling via the growth hormone receptor/JAK2/STAT5B pathway. J. Biol. Chem. 274: 13 434-13 442.
70. Ji, S.N., Frank, S.J., and Messina, J.L. 2002. Growth hormone-induced differential desensitization of STAT5, ERK, and Akt phosphorylation. J. Biol. Chem. 277: 28 384-28 393.
71. Jones, E.J., and Riddick, D.S. 1996. Regulation of constitutive rat hepatic cytochromes P450 by 3-methylcholanthrene. Xenobiotica, 26: 995-1012.
72. Jones, L.C., Okino, S.T., Gonda, T.J., and Whitlock, J.P. 2002. Myb-binding protein 1a augments AhR-dependent gene expression. J. Biol. Chem. 277: 22 515-22 519.
73. Kamataki, T., Maeda, K., Shimada, M., and Kato, R. 1986. Effects of phenobarbital, 3-methylcholanthrene and polychlorinated biphenyls on sex-specific forms of cytochrome P-450 in liver microsomes of rats. J. Biochem. 99: 841-845.
74. Kazlauskas, A., Poellinger, L., and Pongratz, I. 1999. Evidence that the co-chaperone p23 regulates ligand responsiveness of the dioxin (aryl hydrocarbon) receptor. J. Biol. Chem. 274: 13 519-13 524.
75. Kempe, K.C., Isom, H.C., and Greene, F.E. 1995. Responsiveness of an SV40-immortalized hepatocyte cell line to growth hormone. Biochem. Pharmacol. 49: 1091-1098.
76. Kim, J., and Kemper, B. 1997. Phenobarbital alters protein binding to the CYP2B1/2 phenobarbital-responsive unit in native chromatin. J. Biol. Chem. 272: 29 423-29 425.
77. Ko, H.S.P., Okino, S.T., Ma, Q., and Whitlock, J.P. 1996. Dioxin-induced CYP1A1 transcription in vivo: the aromatic hydrocarbon receptor mediates transactivation, enhancer promoter communication, and changes in chromatin structure. Mol. Cell. Biol. 16: 430-436.
78. Ko, H.P., Okino, S.T., Ma, Q., and Whitlock, J.P. 1997. Transactivation domains facilitate promoter occupancy for the dioxin-inducible CYP1A1 gene in vivo. Mol. Cell. Biol. 17: 3497-3507.
79. Kobayashi, A., Numayama-Tsuruta, K., Sogawa, K., and Fujii-Kuriyama, Y. 1997. CBP/p300 functions as a possible transcriptional coactivator of Ah receptor nuclear translocator (Arnt). J. Biochem. 122: 703-710.
80. Kociba, R.J., Keyes, D.G., Beyer, J.E., Carreon, R.M., Wade, C.E., Dittenber, D.A., Kalnins, R.P., Frauson, L.E., Park, C.N., Barnard, S.D., Hummel, R.A., and Humiston, C.G. 1978. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol. Appl. Pharmacol. 46: 279-303.
81. Kip1 induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev. 13: 1742-1753.
82. Konstandi, M., Johnson, E., Lang, M.A., Camus-Radon, A.M., and Marselos, M. 2000. Stress modulates the enzymatic inducibility by benzo[a]pyrene in the rat liver. Pharmacol. Res. 42: 205-211.
83. Krishnan, V., Porter, W., Santostefano, M., Wang, X.H., and Safe, S. 1995. Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells. Mol. Cell. Biol. 15: 6710-6719.
84. Kumar, M.B., Tarpey, R.W., and Perdew, G.H. 1999. Differential recruitment of coactivator RIP140 by Ah and estrogen receptors: absence of a role for LXXL motifs. J. Biol. Chem. 274: 22 155-22 164.
85. Lahvis, G.P., Lindell, S.L., Thomas, R.S., McCuskey, R.S., Murphy, C., Glover, E., Bentz, M., Southard, J., and Bradfield, C.A. 2000. Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 97: 10 442-10 447.
86. LaPres, J.J., Glover, E., Dunham, E.E., Bunger, M.K., and Bradfield, C.A. 2000. ARA9 modifies agonist signaling through an increase in cytosolic aryl hydrocarbon receptor. J. Biol. Chem, 275: 6153-6159.
87. LeBlanc, G.A., and Waxman, D.J. 1988. Feminization of rat hepatic P-450 expression by cisplatin: evidence for perturbations in the hormonal regulation of steroid-metabolizing enzymes. J. Biol. Chem. 263: 15 732-15 739.
88. LeBlanc, G.A., and Waxman, D.J. 1990. Mechanisms of cyclo-phosphamide action on hepatic P-450 expression. Cancer Res. 50: 5720-5726.
89. Lee, C., and Riddick, D.S. 2000. Transcriptional suppression of cytochrome P4502C11 gene expression by 3-methylcholanthrene. Biochem. Pharmacol. 59: 1417-1423.
90. Lee, J.E., and Safe, S. 2000. 3′,4′-Dimethoxyflavone as an aryl hydrocarbon receptor antagonist in human breast cancer cells. Toxicol. Sci. 58: 235-242.
91. 2 promoter activity are localized to the TATA box binding region and controlled through a tyrosine kinase-dependent pathway. Toxicol. Appl. Pharmacol. 137: 90-99.
92. Legraverend, C., Mode, A., Westin, S., Strom, A., Eguchi, H., Zaphiropoulos, P.G., and Gustafsson, J.-A. 1992. Transcriptional regulation of rat P-450 2C gene subfamily members by the sexually dimorphic pattern of growth hormone secretion. Mol. Endocrinol. 6: 259-266.
93. Liddle, C., Mode, A., Legraverend, C., and Gustafsson, J.-A. 1992. Constitutive expression and hormonal regulation of male sexually differentiated cytochromes-P450 in primary cultured rat hepatocytes. Arch. Biochem. Biophys. 298: 159-166.
94. Lin, F.H., Clark, G., Birnbaum, L.S., Lucier, G.W., and Goldstein, J.A. 1991a. Influence of the Ah locus on the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the hepatic epidermal growth factor receptor. Mol. Pharmacol. 39: 307-313.
95. Lin, F.H., Stohs, S.J., Birnbaum, L.S., Clark, G., Lucier, G.W., and Goldstein, J.A. 1991b. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the hepatic estrogen and glucocorticoid receptors in congenic strains of Ah responsive and Ah nonresponsive C57BL/6J mice. Toxicol. Appl. Pharmacol. 108: 129-139.
96. Linder, M.W., Falkner, K.C., Srinivasan, G., Hines, R.N., and Prough, R.A. 1999. Role of canonical glucocorticoid responsive elements in modulating expression of genes regulated by the aryl hydrocarbon receptor. Drug Metab. Rev. 31: 247-271.
97. Liu, S.Q., Rivera-Rivera, I., Bredemeyer, A.J., and Kemper, B. 2001. Functional analysis of the phenobarbital-responsive unit in rat CYP2B2. Biochem. Pharmacol. 62: 21-28.
98. Lucier, G.W., Tritscher, A., Goldsworthy, T., Foley, J., Clark, G., Goldstein, J., and Maronpot, R. 1991. Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increases in cell proliferation and preneoplastic foci in a two-stage model for rat hepatocarcinogenesis. Cancer Res. 51: 1391-1397.
99. Luo, G.Y., and Yu-Lee, L.Y. 2000. Stat5b inhibits NF-κB-mediated signaling. Mol. Endocrinol. 14: 114-123.
100. Lusska, A., Shen, E., and Whitlock, J.P. 1993. Protein-DNA interactions at a dioxin-responsive enhancer: analysis of six bonafide DNA-binding sites for the liganded Ah receptor. J. Biol. Chem. 268: 6575-6580.
101. Ma, Q., and Baldwin, K.T. 2000. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced degradation of aryl hydrocarbon receptor (AhR) by the ubiquitin-proteasome pathway: role of the transcription activaton and DNA binding of AhR. J. Biol. Chem. 275: 8432-8438.
102. Ma, Q., and Whitlock, J.P. 1996. The aromatic hydrocarbon receptor modulates the Hepa 1c1c7 cell cycle and differentiated state independently of dioxin. Mol. Cell. Biol. 16: 2144-2150.
103. Ma, Q., and Whitlock, J.P. 1997. A novel cytoplasmic protein that interacts with the Ah receptor, contains tetratricopeptide repeat motifs, and augments the transcriptional response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Biol. Chem. 272: 8878-8884.
104. Ma, Q., Renzelli, A.J., Baldwin, K.T., and Antonini, J.M. 2000. Superinduction of CYP1A1 gene expression: regulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced degradation of Ah receptor by cycloheximide. J. Biol. Chem. 275: 12 676-12 683.
105. Masten, S.A., and Shiverick, K.T. 1995. The Ah receptor recognizes DNA binding sites for the B cell transcription factor, BSAP: a possible mechanism for dioxin-mediated alteration of CD19 gene expression in human B lymphocytes. Biochem. Biophys. Res. Commun. 212: 27-34.
106. Mathis, J.M., Houser, W.H., Bresnick, E., Cidlowski, J.A., Hines, R.N., Prough, R.A., and Simpson, E.R. 1989. Glucocorticoid regulation of the rat cytochrome P450c (P450IA1) gene: receptor binding within intron I. Arch. Biochem. Biophys. 269: 93-105.
107. Meyer, B.K., Pray-Grant, M.G., VandenHeuvel, J.P., and Perdew, G.H. 1998. Hepatitis B virus X-associated protein 2 is a subunit of the unliganded aryl hydrocarbon receptor core complex and exhibits transcriptional enhancer activity. Mol. Cell. Biol. 18: 978-988.
108. Mimura, J., Yamshita, K., Nakamura, K., Morita, M., Takagi, T.N., Nakao, K., Ema, M., Sogawa, K., Yasuda, M., Katsuki, M., and Fujii-Kuriyama, Y. 1997. Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells, 2: 645-654.
109. Mimura, J., Ema, M., Sogawa, K., and Fujii-Kuriyama, Y. 1999. Identification of a novel mechanism of regulation of Ah (dioxin) receptor function. Genes Dev. 13: 20-25.
110. Morgan, E.T. 1997. Regulation of cytochromes P450 during inflammation and infection. Drug Metab. Rev. 29: 1129-1188.
111. Morgan, E.T. 2001. Regulation of cytochrome P450 by inflammatory mediators: why and how? Drug Metab. Dispos. 29: 207-212.
112. Morgan, J.E., and Whitlock, J.P. 1992. Transcription-dependent and transcription-independent nucleosome disruption induced by dioxin. Proc. Natl. Acad. Sci. U.S.A. 89: 11 622-11 626.
113. Morgan, E.T., MacGeoch, C., and Gustafsson, J.-A. 1985. Hormonal and developmental regulation of expression of the hepatic microsomal steroid 16α-hydroxylase cytochrome P-450 apoprotein in the rat. J. Biol. Chem. 260: 11 895-11 898.
114. Morishima, N., Yoshioka, H., Higashi, Y., Sogawa, K., and Fujii-Kuriyama, Y. 1987. Gene structure of cytochrome P-450(M-1) specifically expressed in male rat liven Biochemistry. 26: 8279-8285.
115. Nakayama, K., Sudo, Y., Sasaki, Y., Iwata, H., Takahashi, M., and Kamataki, T. 2001. Studies on transcriptional regulation of Cyp3a16 gene in mouse livers by application of direct DNA injection method. Biochem. Biophys. Res. Commun. 287: 820-824.
116. Nguyen, T.A., Hoivik, D., Lee, J.E., and Safe, S. 1999. Interactions of nuclear receptor coactivator/corepressor proteins with the aryl hydrocarbon receptor complex. Arch. Biochem. Biophys. 367: 250-257.
117. Oakley, G.G., Roe, A.L., Blouin, R.A., Twaroski, T.P., Ganguly, T.C., Vore, M., Lehmler, H.J., and Robertson, L.W. 2001.2,4,4′-Trichlorobiphenyl increases STAT5 transcriptional activity. Mol. Carcinogenesis, 30: 199-208.
118. Okey, A.B., Bondy, G.P., Mason, M.E., Nebert, D.W., Forster-Gibson, C.J., Muncan, J., and Dufresne, M.J. 1980. Temperature-dependent cytosol-to-nucleus translocation of the Ah recepture-dependent for 2,3,7,8-tetrachlorodibenzo-p-dioxin in continuous cell culture lines. J. Biol. Chem. 255: 11 415-11 422.
119. Okey, A.B., Riddick, D.S., and Harper, P.A. 1994a. The Ah receptor: mediator of the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. Toxicol. Lett. 70: 1-22.
120. Okey, A.B., Riddick, D.S., and Harper, P.A. 1994b. Molecular biology of the aromatic hydrocarbon (dioxin) receptor. Trends Pharmacol. Sci. 15: 226-232.
121. Okino, S.T., and Whitlock, J.P. 1995. Dioxin induces localized, graded changes in chromatin structure: implications for Cyplal gene transcription. Mol. Cell. Biol. 15: 3714-3721.
122. Park, S.H., and Waxman, D.J. 2001. Inhibitory cross-talk between STAT5b and liver nuclear factor HNF3β: impact on the regulation of growth hormone pulse-stimulated, male-specific liver cytochrome P-450 gene expression. J. Biol. Chem. 276: 43 031-43 039.
123. Park, Y.K., Li, H., and Kemper, B. 1996. Phenobarbital induction mediated by a distal CYP2B2 sequence in rat liver transiently transfected in situ. J. Biol. Chem. 271: 23 725-23 728.
124. Park, S.H., Liu, X.W., Hennighausen, L., Davey, H.W., and Waxman, D.J. 1999. Distinctive roles of STAT5a and STAT5b in sexual dimorphism of hepatic P450 gene expression: impact of Stat5a gene disruption. J. Biol. Chem. 274: 7421-7430.
125. Perdew, G.H. 1988. Association of the Ah receptor with the 90-kDa heat shock protein. J. Biol. Chem. 263: 13 802-13 805.
126. Peters, J.M., Narotsky, M.G., Elizondo, G., Fernandez-Salguero, P.M., Gonzalez, F.J., and Abbott, B.D. 1999. Amelioration of TCDD-induced teratogenesis in aryl hydrocarbon receptor (AhR)-null mice. Toxicol. Sci. 47: 86-92.
127. Piechocki, M.P., and Hines, R.N. 1998. Functional characterization of the human CYP1A1 negative regulatory element: modulation of Ah receptor mediated transcriptional activity. Carcinogenesis 19: 771-780.
128. Poland, A., and Knutson, J.C. 1982. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 22: 517-554.
129. Pollenz, R.S. 1996. The aryl-hydrocarbon receptor, but not the aryl-hydrocarbon receptor nuclear translocator protein, is rapidly depleted in hepatic and nonhepatic culture cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol. Pharmacol. 49: 391-398.
130. Pollenz, R.S., Sattler, C.A., and Poland, A. 1994. The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa 1c1c7 cells by immunofluorescence microscopy. Mol. Pharmacol. 45: 428-438.
131. Pollenz, R.S., Santostefano, M.J., Klett, E., Richardson, V.M., Necela, B., and Birnbaum, L.S. 1998. Female Sprague-Dawley rats exposed to a single oral dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin exhibit sustained depletion of aryl hydrocarbon receptor protein in liver, spleen, thymus, and lung. Toxicol. Sci. 42: 117-128.
132. Porter, W., Wang, F., Duan, R., Qin, C., Castro-Rivera, E., Kim, K., and Safe, S. 2001. Transcriptional activation of heat shock protein 27 gene expression by 17β-estradiol and modulation by antiestrogens and aryl hydrocarbon receptor agonists. J. Mol. Endocrinol. 26: 31-42.
133. Powell-Coffman, J.A., Bradfield, C.A., and Wood, W.B. 1998. Caenorhabditis elegans orthologs of the aryl hydrocarbon receptor and its heterodimerization partner the aryl hydrocarbon receptor nuclear translocator. Proc. Natl. Acad. Sci. U.S.A. 95: 2844-2849.
134. Puga, A., Maier, A., and Medvedovic, M. 2000. The transcriptional signature of dioxin in human hepatoma HepG2 cells. Biochem. Pharmacol. 60: 1129-1142.
135. Ram, P.A., and Waxman, D.J. 1991. Hepatic P450 expression in hypothyroid rats: differential responsiveness of male-specific P450 form-2a (IIIA2), form-2c (IIC11), and RLM2 (IIA2) to thyroid hormone. Mol. Endocrinol. 5: 13-20.
136. Renton, K.W. 2001. Alteration of drug biotransformation and elimination during infection and inflammation. Pharmacol. Ther. 92: 147-163.
137. Reyes, H., Reisz-Porszasz, S., and Hankinson, O. 1992. Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science (Washington, D.C.), 256: 1193-1195.
138. Rivera, S.P., Saarikoski, S.T., and Hankinson, O. 2002. Identification of a novel dioxin-inducible cytochrome P450. Mol. Pharmacol. 61: 255-259.
139. Roberts, S.G.E., and Green, M.R. 1995. Dichotomous regulators. Nature (London), 375: 105-106.
140. Rodgman, A., Smith, C.J., and Perfetti, T.A. 2000. The composition of cigarette smoke: a retrospective, with emphasis on polycyclic components. Hum. Exp. Toxicol. 19: 573-595.
141. Rowlands, J.C., McEwan, I.J., and Gustafsson, J.-A. 1996. Transactivation by the human aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator proteins: direct interactions with basal transcription factors. Mol. Pharmacol. 50: 538-548.
142. Safa, B., Lee, C., and Riddick, D.S. 1997. Role of the aromatic hydrocarbon receptor in the suppression of cytochrome P-450 2C11 by polycyclic aromatic hydrocarbons. Toxicol. Lett. 90: 163-175.
143. Safe, S.H. 1995. Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Pharmacol. Ther. 67: 247-281.
144. Sasaki, Y., Takahashi, Y., Nakayama, K., and Kamataki, T. 1999. Cooperative regulation of CYP2C12 gene expression by STAT5 and liver-specific factors in female rats. J. Biol. Chem. 274: 37 117-37 124.
145. Savouret, J.F., Antenos, M., Quesno, M., Xu, J., Milgrom, E., and Casper, R.F. 2001. 7-Ketocholesterol is an endogenous modulator for the aryl hydrocarbon receptor. J. Biol. Chem. 276: 3054-3059.
146. 4: a new class of ligand for the Ah receptor. Biochemistry, 38: 7594-7600.
147. Schmidt, J.V., Su, G.H.T., Reddy, J.K., Simon, M.C., and Bradfield, C.A. 1996. Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc. Natl. Acad. Sci. U.S.A. 93: 6731-6736.
148. Schuetz, E., Lan, L.B., Yasuda, K., Kim, R., Kocarek, T.A., Schuetz,
149. Semenza, G.L., Nejfelt, M.K., Chi, S.M., and Antonarakis, S.E. 1991. Hypoxia-inducible nuclear factors bind to an enhancer element 3′ to the human erythropoietin gene. Proc. Natl. Acad. Sci. U.S.A. 88: 5680-5684.
150. Serron, S.C., Zhang, S., Bergeron, R.M., and Backes, W.L. 2001. Effect of hypophysectomy and growth hormone replacement on the modulation of P450 expression after treatment with the aromatic hydrocarbon ethylbenzene. Toxicol. Appl. Pharmacol. 172: 163-171.
151. Shertzer, H.G., Nebert, D.W., Puga, A., Ary, M., Sonntag, D., Dixon, K., Robinson, L.J., Cianciolo, E., and Dalton, T.P. 1998. Dioxin causes a sustained oxidative stress response in the mouse. Biochem. Biophys. Res. Commun. 253: 44-48.
152. Shimada, M., Murayama, N., Yamauchi, K., Yamazoe, Y., and Kato, R. 1989. Suppression in the expression of a male-specific cytochrome P450, P450-male: difference in the effect of chemical inducers on P450-male mRNA and protein in rat livers. Arch. Biochem. Biophys. 270: 578-587.
153. Shimizu, Y., Nakatsuru, Y., Ichinose, M., Takahashi, Y., Kume, H., Mimura, J., Fujii-Kuriyama, Y., and Ishikawa, T. 2000. Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. U.S.A. 97: 779-782.
154. Sinal, C.J., and Bend, J.R. 1997. Aryl hydrocarbon receptor-dependent induction of Cyp1a1 by bilirubin in mouse hepatoma Hepa 1c1c7 cells. Mol. Pharmacol. 52: 590-599.
155. Spink, D.C., Eugster, H.P., Lincoln, D.W., Schuetz, J.D., Schuetz, E.G., Johnson, J.A., Kaminsky, L.S., and Gierthy, J.F. 1992. 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1A1: a comparison of the activities induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA. Arch. Biochem. Biophys. 293: 342-348.
156. Stoltz, C., Vachon, M.H., Trottier, E., Dubois, S., Paquet, Y., and Anderson, A. 1998. The CYP2B2 phenobarbital response unit contains an accessory factor element and a putative glucocorticoid response element essential for conferring maximal phenobarbital responsiveness. J. Biol. Chem. 273: 8528-8536.
157. Strom, A., Eguchi, H., Mode, A., Legraverend, C., Tollet, P., Stromstedt, P.E., and Gustafsson, J.-A. 1994. Characterization of the proximal promoter and two silencer elements in the CYP2C11 gene expressed in rat liver. DNA Cell Biol. 13: 805-819.
158. Strom, A., Westin, S., Eguchi, H., Gustafsson, J.-A., and Mode, A. 1995. Characterization of orphan nuclear receptor binding elements in sex-differentiated members of the CYP2C gene family expressed in rat liver. J. Biol. Chem. 270: 11 276-11 281.
159. Sueyoshi, T., Yokomori, N., Korach, K.S., and Negishi, M. 1999. Developmental action of estrogen receptor-α feminizes the growth hormone-Stat5b pathway and expression of Cyp2a4 and Cyp2d9 genes in mouse liver. Mol. Pharmacol. 56: 473-477.
160. Sundseth, S.S., Alberta, J.A., and Waxman, D.J. 1992. Sex-specific, growth hormone-regulated transcription of the cytochrome-P450 2C11 and 2C12 genes. J. Biol. Chem. 267: 3907-3914.
161. Sutter, T.R., Guzman, K., Dold, K.M., and Greenlee, W.F. 1991. Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-1β. Science (Washington, D.C.), 254: 415-418.
162. Swanson, H.I., and Yang, J.H. 1998. The aryl hydrocarbon receptor interacts with transcription factor IIB. Mol. Pharmacol. 54: 671-677.
163. Takahashi, Y., Nakayama, K., Itoh, S., Fujii-Kuriyama, Y., and Kamataki, T. 1997. Inhibition of the transcription of CYP1A1 gene by the upstream stimulatory factor 1 in rabbits: competitive binding of USF1 with AhR•Arnt complex. J. Biol. Chem. 272: 30 025 - 30 031.
164. Taylor, B.L., and Zhulin, I.B. 1999. PAS domains: internal sensors of oxygen, redox potential, and light. Microbiol. Mol. Biol. Rev. 63: 479-506.
165. Teglund, S., McKay, C., Schuetz, E., van Deursen, J.M., Stravopodis, D., Wang, D., Brown, M., Bodner, S., Grosveld, G., and Ihle, J.N. 1998. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell, 93: 841-850.
166. Tian, Y., Ke, S., Denison, M.S., Rabson, A.B., and Gallo, M.A. 1999. Ah receptor and NF-κB interactions, a potential mechanism for dioxin toxicity. J. Biol. Chem. 274: 510-515.
167. Timsit, Y.E., and Riddick, D.S. 2000. Interference with growth hormone stimulation of hepatic cytochrome P4502C11 expression in hypophysectomized male rats by 3-methylcholanthrene. Toxicol. Appl. Pharmacol. 163: 105-114.
168. Timsit, Y.E., and Riddick, D.S. 2002. Stimulation of hepatic signal transducer and activator of transcription 5b by GH is not altered by 3-methylcholanthrene. Endocrinology, 143: 3284-3294.
169. Timsit, Y.E., Chia, F.S.-C., Bhathena, A., and Riddick, D.S. 2002. Aromatic hydrocarbon receptor expression and function in liver of hypophysectomized male rats. Toxicol. Appl. Pharmacol. 185: 136-145.
170. 1-450 induction by use of a cloned cDNA sequence. J. Biol. Chem. 256: 6969-6974.
171. Udy, G.B., Towers, R.P., Snell, R.G., Wilkins, R.J., Park, S.H., Ram, P.A., Waxman, D.J., and Davey, H.W. 1997. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. U.S.A. 94: 7239-7244.
172. Venepally, P., Chen, D., and Kemper, B. 1992. Transcriptional regulatory elements for basal expression of cytochrome P450IIC genes. J. Biol. Chem. 267: 17 333-17 338.
173. Wang, S., and Hankinson, O. 2002. Functional involvement of the Brahma/SW12-related gene 1 protein in cytochrome P4501A1 transcription mediated by the aryl hydrocarbon receptor complex. J. Biol. Chem. 277: 11 821-11 827.
174. Wang, F., Samudio, I., and Safe, S. 2001. Transcriptional activation of cathepsin D gene expression by 17β-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition. Mol. Cell. Endocrinol. 172: 91-103.
175. Waxman, D.J. 1984. Rat hepatic cytochrome P-450 isozyme 2c: identification as a male-specific, developmentally induced steroid 16α-hydroxylase and comparison to a female-specific cytochrome P-450 isoenzyme. J. Biol. Chem. 259: 15 481-15 490.
176. Waxman, D.J., and Chang, T.K.H. 1995. Hormonal regulation of liver cytochrome P450 enzymes. In Cytochrome P450: structure, mechanism, and biochemistry. 2nd ed. Edited by P.R. Ortiz de Montellano. Plenum Press, New York, NY. pp. 391-417.
177. Waxman, D.J., and Frank, S.J. 2000. Growth hormone action: signaling via a JAK/STAT-coupled receptor. In Principles of molecular regulation. Edited by P.M. Conn and A.R. Means. Humana Press Inc, Totowa, N.J. pp. 55-83.
178. Waxman, D.J., Dannan, G.A., and Guengerich, F.P. 1985. Regulation of rat hepatic cytochrome P-450: age-dependent expression, hormonal imprinting, and xenobiotic inducibility of sex-specific isoenzymes. Biochemistry, 24: 4409-4417.
179. Waxman, D.J., Pampori, N.A., Ram, P.A., Agrawal, A.K., and Shapiro, B.H. 1991. Interpulse interval in circulating growth hormone patterns regulates sexually dimorphic expression of hepatic cytochrome-P450. Proc. Natl. Acad. Sci. U.S.A. 88: 6868-6872.
180. Waxman, D.J., Ram, P.A., Park, S.H., and Choi, H.K. 1995. Intermittent plasma growth hormone triggers tyrosine phosphorylation and nuclear translocation of a liver-expressed, Stat 5-related DNA binding protein: proposed role as an intracellular regulator of male-specific liver gene transcription. J. Biol. Chem. 270: 13 262-13 270.
181. Whitlock, J.P. 1999. Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol. 39: 103-125.
182. Wood, T.J.J., Sliva, D., Lobie, P.E., Pircher, T.J., Gouilleux, F., Wakao, H., Gustafsson, J.-A., Groner, B., Norstedt, G., and Haldosen, L.A. 1995. Mediation of growth hormone-dependent transcriptional activation by mammary gland factor Stat 5. J. Biol. Chem. 270: 9448-9453.
183. Wright, K., and Morgan, E.T. 1990. Transcriptional and post-transcriptional suppression of P450IIC11 and P450IIC12 by inflammation. FEBS Lett. 271: 59-61.
184. Wu, L., and Whitlock, J.P. 1993. Mechanism of dioxin action: receptor-enhancer interactions in intact cells. Nucleic Acids Res. 21: 119-125.
185. Xiang, S.H., Parsons, H.K., and Murray, M. 1998. Identification of a novel transcriptional silencer in the protein-coding region of the human CYP2C9 gene. Gene, 209: 123-129.
186. Xu, L., Ruh, T.S., and Ruh, M.F. 1997. Effect of the histone deacetylase inhibitor trichostatin A on the responsiveness of rat hepatocytes to dioxin. Biochem. Pharmacol. 53: 951-957.
187. Yao, E.F., and Denison, M.S. 1992. DNA sequence determinants for binding of transformed Ah-receptor to a dioxin-responsive enhancer. Biochemistry, 31: 5060-5067.
188. Yeowell, H.N., Waxman, D.J., Wadhera, A., and Goldstein, J.A. 1987. Suppression of the constitutive, male-specific rat hepatic cytochrome P-4502c and its mRNA by 3,4,5,3′,4′,5′-hexachlorobiphenyl and 3-methylcholanthrene. Mol. Pharmacol. 32: 340-347.
189. Yeowell, H.N., Waxman, D.J., LeBlanc, G.A., Linko, P., and Goldstein, J.A. 1989. Suppression of male-specific cytochrome P450 2c and its mRNA by 3,4,5,3′,4′,5′-hexachlorobiphenyl in rat liver is not causally related to changes in serum testosterone. Arch. Biochem. Biophys. 271: 508-514.
190. Yoshihara, S., Nagata, K., Wada, I., Yoshimura, H., Kuroki, H., and Masuda, Y. 1982. A unique change of steroid metabolism in rat liver microsomes induced with highly toxic polychlorinated biphenyl (PCB) and polychlorinated dibenzofuran (PCDF). J. Pharmacobiodyn. 5: 994-1004.
191. Yoshinari, K., Sueyoshi, T., Moore, R., and Negishi, M. 2001. Nuclear receptor CAR as a regulatory factor for the sexually dimorphic induction of CYP2B1 gene by phenobarbital in rat livers. Mol. Pharmacol. 59: 278-284.
192. Yoshioka, H., Morohashi, K.-I., Sogawa, K., Miyata, T., Kawajiri, K., Hirose, T., Inayama, S., Fujii-Kuriyama, Y., and Omura, T. 1987. Structural analysis and specific expression of microsomal cytochrome P-450(M-1) mRNA in male rat livers. J. Biol. Chem. 262: 1706-1711.
193. Zacharewski, T., Harris, M., and Safe, S. 1991. Evidence for the mechanism of action of the 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated decrease of nuclear estrogen receptor levels in wild-type and mutant mouse Hepa-1c1c7 cells. Biochem. Pharmacol. 41: 1931-1939.
194. Zacharewski, T.R., Bondy, K.L., McDonell, P., and Wu, Z.F. 1994. Antiestrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17β-estradiol-induced pS2 expression. Cancer Res. 54: 2707-2713.
195. Zhou, Y.C., and Waxman, D.J. 1999a. Cross-talk between Janus kinase-signal transducer and activator of transcription (JAKSTAT) and peroxisome proliferator-activated receptor-α (PPARα) signaling pathways: growth hormone inhibition of PPARα transcriptional activity mediated by STAT5b. J. Biol. Chem. 274: 2672-2681.
196. Zhou, Y.C., and Waxman, D.J. 1999b. STAT5b downregulates peroxisome proliferator-activated receptor-α transcription by inhibition of ligand-independent activation function region-1 trans-activation domain. J. Biol. Chem. 274: 29 874-29 882.